Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
Open Access
- 17 June 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 14 (1), 335
- https://doi.org/10.1186/1471-2334-14-335
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomesBMC Infectious Diseases, 2012
- Longitudinal Analysis of Pneumococcal Antibodies during Community-Acquired Pneumonia Reveals a Much Higher Involvement of Streptococcus pneumoniae than Estimated by Conventional Methods AloneClinical and Vaccine Immunology, 2011
- Systemic cytokine response in patients with community-acquired pneumoniaEuropean Respiratory Journal, 2010
- Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trialBMJ, 2010
- Late Admission to the ICU in Patients With Community-Acquired Pneumonia Is Associated With Higher MortalityChest, 2010
- Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populationsVaccine, 2009
- Health and Functioning Among Baby Boomers Approaching 60The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2009
- Efficacy of pneumococcal vaccination in adults: a meta-analysisCMAJ : Canadian Medical Association Journal, 2009
- Determinants of hospital costs in community-acquired pneumoniaEuropean Respiratory Journal, 2008
- Resource Use and Cost of Care for Patients Hospitalised with Community Acquired PneumoniaPharmacoEconomics, 2004